You are here: Industry Insights > Suboxone

News List

Indivior to pay $600m to settle opioid drug marketing claims pharmaceutical-technology
July 28, 2020
Indivior has reached an agreement to pay $600m to settle US claims that the company had run an illegal scheme to increase prescriptions of its opioid addiction treatment, Suboxone.
Company Reaches $1.4 Billion Settlement in Opioid Treatment Investigation drugs
July 16, 2019
Company Reaches $1.4 Billion Settlement in Opioid Treatment Investigation.
Indivior's former parent ponies up a whopping $1.4B to settle Suboxone marketing probe fiercepharma
July 13, 2019
With the feds sniffing around Indivior’s aggressive marketing of its opioid addiction treatment Suboxone, the forecast looked bleak for the drugmaker.
Indivior indicted in US over marketing practices for opioid addiction treatment Suboxone Film; shares crash firstwordpharma
April 11, 2019
Indivior indicted in US over marketing practices for opioid addiction treatment Suboxone Film; shares crash.
Mylan Launches Generic Suboxone Sublingual Film americanpharmaceuticalreview
February 26, 2019
Mylan announced the U.S. launch of Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg and 12 mg/3 mg, a generic version of Indivior's Suboxone® Sublingual Film....
Indivior faces huge sales loss as Suboxone court loss puts generics on tap next week fiercepharma
February 24, 2019
Indivior has been fighting off generics to its top-selling Suboxone film, but a federal appeals court has unleashed copycats now charging toward launches next week.
Indivior Announces Launch of SUBOXONE Sublingual Film Generic americanpharmaceuticalreview
February 22, 2019
Indivior announced its U.S. affiliate, Indivior Inc., has launched an authorized generic version of SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) in the U.S. The authorized generic is being marketed and .....
Indivior launches generic version of Suboxone sublingual film pharmaceutical-technology
February 21, 2019
UK-based pharmaceutical company Indivior has launched a generic version of its Suboxone (buprenorphine and naloxone) sublingual film in the US for the treatment of opioid dependence....
Indivior's new antipsychotic wins FDA nod, but Suboxone patent fight could delay its launch fiercepharma
August 01, 2018
Just as Indivior stalled Dr. Reddy’s rollout of a generic to its top-selling drug, Suboxone Film, the launch of a new drug of Indivior’s own might become collateral damage of the patent fight and the slow ramp-up of fellow newcomer Sublocade.
Indivior's new antipsychotic wins FDA nod, but Suboxone patent fight could delay its launch fiercepharma
July 31, 2018
Just as Indivior stalled Dr. Reddy’s rollout of a generic to its top-selling drug, Suboxone Film, the launch of a new drug of Indivior’s own might become collateral damage of the patent fight and the slow ramp-up of fellow newcomer Sublocade.